DK2379722T3 - Ekspressionsvektor - Google Patents

Ekspressionsvektor

Info

Publication number
DK2379722T3
DK2379722T3 DK09798882.8T DK09798882T DK2379722T3 DK 2379722 T3 DK2379722 T3 DK 2379722T3 DK 09798882 T DK09798882 T DK 09798882T DK 2379722 T3 DK2379722 T3 DK 2379722T3
Authority
DK
Denmark
Prior art keywords
expression
Prior art date
Application number
DK09798882.8T
Other languages
English (en)
Inventor
Thomas Greiner-Stöffele
Meike Ballschmitter
Marc Struhalla
Rico Czaja
Original Assignee
C-Lecta Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C-Lecta Gmbh filed Critical C-Lecta Gmbh
Application granted granted Critical
Publication of DK2379722T3 publication Critical patent/DK2379722T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/40—Systems of functionally co-operating vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK09798882.8T 2008-12-16 2009-12-15 Ekspressionsvektor DK2379722T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08021794 2008-12-16
PCT/EP2009/008977 WO2010075956A1 (de) 2008-12-16 2009-12-15 Expressionsvektor

Publications (1)

Publication Number Publication Date
DK2379722T3 true DK2379722T3 (da) 2017-01-02

Family

ID=40636851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09798882.8T DK2379722T3 (da) 2008-12-16 2009-12-15 Ekspressionsvektor

Country Status (4)

Country Link
US (2) US20120021950A1 (da)
EP (1) EP2379722B1 (da)
DK (1) DK2379722T3 (da)
WO (1) WO2010075956A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220364104A1 (en) * 2012-08-05 2022-11-17 Absci Llc Vectors for use in an inducible coexpression system
US20150353940A1 (en) * 2013-08-05 2015-12-10 Absci, Llc Vectors for use in an inducible coexpression system
EP2860256B1 (en) * 2013-10-11 2017-03-08 CJ Cheiljedang Corporation Method of producing l-amino acids
US9951392B2 (en) * 2014-03-14 2018-04-24 Northwestern University Substrate replenishment and byproduct removal improve yeast cell-free protein synthesis
CN121203988A (zh) 2014-04-22 2025-12-26 C-乐克塔股份有限公司 酮还原酶
CA2965485A1 (en) * 2014-10-21 2016-04-28 Martin R. Schiller Methods and compositions for screening molecular function comprising chimeric minimotifs
EP4316500A3 (en) * 2015-05-13 2024-04-10 CSL Behring Gene Therapy, Inc. Bio-production of lentiviral vectors
EP3307880B1 (en) 2015-06-12 2021-11-10 c-LEcta GmbH Transaminases
WO2024137857A1 (en) * 2022-12-22 2024-06-27 Tevard Biosciences, Inc. Conditional expression of a gene of interest by convergent promoters and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011231A1 (en) 1996-09-10 1998-03-19 The Rockefeller University Highly regulable promoter for heterologous gene expression
US7005423B1 (en) 1999-07-02 2006-02-28 Devgen Nv Characterization of gene function using double stranded RNA inhibition
GB9827152D0 (en) 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6689573B1 (en) 1999-05-24 2004-02-10 New England Biolabs, Inc. Method for screening restriction endonucleases
US6780405B1 (en) 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
AU2002311756A1 (en) 2001-01-18 2002-10-28 Clontech Laboratories, Inc. Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20040002690A1 (en) 2002-07-01 2004-01-01 The Procter & Gamble Company Disposable absorbent article having elasticized outer leg cuff
DK1616012T3 (da) 2003-04-24 2008-04-21 San Raffaele Centro Fond Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser deraf
DE10350474C5 (de) 2003-10-23 2009-09-17 C-Lecta Gmbh Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen
EP2097529A4 (en) * 2006-12-29 2010-03-24 Osprey Pharmaceuticals Usa Inc METHOD FOR SELECTION AND PRODUCTION OF MODIFIED TOXINS, MODIFIED TOXINE CONJUGATES AND USES THEREOF

Also Published As

Publication number Publication date
WO2010075956A1 (de) 2010-07-08
US20160194647A1 (en) 2016-07-07
US20120021950A1 (en) 2012-01-26
EP2379722B1 (de) 2016-09-07
EP2379722A1 (de) 2011-10-26
US10196645B2 (en) 2019-02-05

Similar Documents

Publication Publication Date Title
FIC20250022I1 (fi) Atetsolitsumabi
NO2019015I1 (no) tezakaftor
NL300965I2 (nl) Patisiran
NL300961I2 (nl) Erenumab
NO2018009I1 (no) Dupilumab
NO2017048I1 (no) lotilaner
FIC20170031I1 (fi) alirokumabi
DK2370462T3 (da) Glucagon-analoger
DK2342317T3 (da) Hængende-dråbe-plade
BRPI0907376A2 (pt) Fotobiorretador
NL301273I2 (nl) vamorolone
NO2016023I2 (no) Glycerolfenylbutyrat
PA8805201A1 (es) Piperidinas heteroaril-sustituidas
DK2379557T3 (da) Aminopyrazol-forbindelse
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
BRPI0907522A2 (pt) biarlamidas
EP2339366A4 (en) DEVICE FOR OPTICAL DISTANCE MEASUREMENT
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009001946A5 (de) Mobelauszugsführung
BRPI0909637A2 (pt) 2-aminoquinolinas
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
AT507449A3 (de) Dämmstoffbefestiger
BRPI0822880A2 (pt) alfa-mercapto-amidas
FI20080325A0 (fi) Pihkaliuos